GlassScriptPhysician profile
Sangeeta Mandapaka
NPI 1932309291
$4,625.96
in general payments reported to CMS, 2019-2025
11 companies · $304 in 2025
The $304 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.00 · 2020: $102 · 2021: $205 · 2022: $282 · 2023: $182 · 2024: $3,481 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,195 · Travel and Lodging: $1,772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,195.04 |
| Travel and Lodging | $1,771.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,965.64 | 2024 | Optis, Dragonfly Opstar |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $806.80 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $751.70 | 2023-2025 | Avvigo Guidance System, Rotapro, Wolverine Coronary Cutting Balloon |
| Shockwave Medical, INC | $706.23 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Medical L6 Intravascular Lithotripsy (Ivl) Catheter |
| Teleflex LLC | $133.85 | 2024 | Manta |
| Abiomed | $95.17 | 2022 | |
| Penumbra, INC. | $91.06 | 2025 | Penumbra System |
| Novartis Pharmaceuticals Corporation | $22.00 | 2022 | |
| Recor Medical INC | $21.45 | 2025 | Paradise Ultrasound Renal Denervation System |
| Medtronic, INC. | $16.40 | 2022 | |
| Philips North America LLC | $15.66 | 2025 | Ineb Devices |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sangeeta Mandapaka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.